Applied Net Working Capital vs Capital Surpluse Analysis
APDN Stock | USD 0.60 0.01 1.64% |
Applied DNA financial indicator trend analysis is way more than just evaluating Applied DNA Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Applied DNA Sciences is a good investment. Please check the relationship between Applied DNA Net Working Capital and its Capital Surpluse accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Net Working Capital vs Capital Surpluse
Net Working Capital vs Capital Surpluse Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Applied DNA Sciences Net Working Capital account and Capital Surpluse. At this time, the significance of the direction appears to have very week relationship.
The correlation between Applied DNA's Net Working Capital and Capital Surpluse is 0.24. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Applied DNA Sciences, assuming nothing else is changed. The correlation between historical values of Applied DNA's Net Working Capital and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of Applied DNA Sciences are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Net Working Capital i.e., Applied DNA's Net Working Capital and Capital Surpluse go up and down completely randomly.
Correlation Coefficient | 0.24 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Net Working Capital
Capital Surpluse
Most indicators from Applied DNA's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Applied DNA Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. As of the 2nd of June 2024, Selling General Administrative is likely to drop to about 10 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 10.3 M
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 18.2M | 13.4M | 15.4M | 16.1M | Research Development | 3.9M | 3.7M | 4.3M | 4.5M |
Applied DNA fundamental ratios Correlations
Click cells to compare fundamentals
Applied DNA Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Applied DNA fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Current Liabilities | 4.3M | 3.3M | 4.2M | 2.8M | 3.3M | 3.9M | |
Total Stockholder Equity | 5.7M | 11.1M | 12.9M | 5.0M | 5.7M | 6.0M | |
Retained Earnings | (269.8M) | (284.1M) | (292.5M) | (302.4M) | (272.2M) | (258.6M) | |
Accounts Payable | 1.3M | 2.0M | 1.7M | 1.1M | 1.2M | 921.1K | |
Common Stock Shares Outstanding | 196.0K | 345.9K | 448.4K | 653.8K | 751.8K | 789.4K | |
Non Current Liabilities Total | 1.4M | 31.5K | 5.2M | 5.9M | 6.8M | 7.2M | |
Other Stockholder Equity | 275.5M | 295.2M | 305.4M | 307.4M | 353.5M | 371.2M | |
Total Liab | 5.6M | 3.3M | 9.4M | 8.8M | 10.1M | 10.6M | |
Common Stock | 5.1K | 7.5K | 12.9K | 13.7K | 12.3K | 11.7K | |
Other Current Liab | 676.4K | 980.9K | 1.9M | 1.2M | 1.1M | 1.1M | |
Total Assets | 11.3M | 14.4M | 22.3M | 13.7M | 15.7M | 16.5M | |
Net Debt | (5.4M) | (6.6M) | (15.2M) | (5.9M) | (5.3M) | (5.1M) | |
Cash | 7.8M | 6.6M | 15.2M | 7.2M | 8.2M | 8.6M | |
Cash And Short Term Investments | 7.8M | 6.6M | 15.2M | 7.2M | 8.2M | 8.6M | |
Liabilities And Stockholders Equity | 11.3M | 14.4M | 22.3M | 13.7M | 15.7M | 16.5M | |
Total Current Assets | 9.1M | 11.3M | 19.9M | 8.1M | 9.3M | 5.0M | |
Non Current Assets Total | 2.3M | 3.1M | 2.3M | 5.5M | 6.4M | 6.7M | |
Intangible Assets | 864.2K | 734.8K | 605.3K | 2.7M | 2.4M | 2.6M | |
Property Plant And Equipment Net | 1.3M | 3.0M | 2.2M | 2.1M | 2.4M | 2.5M | |
Current Deferred Revenue | 511.0K | 281K | 563.6K | 76.4K | 68.8K | 65.4K | |
Non Currrent Assets Other | 95.1K | 95.0K | 99.0K | 750K | 862.5K | 905.6K | |
Property Plant And Equipment Gross | 1.3M | 3.8M | 4.3M | 5.5M | 6.3M | 6.6M | |
Net Receivables | 194.3K | 2.8M | 3.1M | 255.5K | 293.8K | 279.1K | |
Other Current Assets | 599.3K | 568.9K | 1.1M | 389.2K | 447.6K | 373.6K | |
Net Tangible Assets | (1.9M) | 4.8M | 11.1M | 12.9M | 14.8M | 15.6M | |
Property Plant Equipment | 226.2K | 1.3M | 3.0M | 2.2M | 2.6M | 2.7M | |
Other Assets | 172.0K | 95.1K | 95.0K | 99.0K | 89.1K | 84.6K | |
Inventory | 497.4K | 1.4M | 602.2K | 330.0K | 379.5K | 347.2K | |
Other Liab | 622.0K | 848.3K | 31.5K | 5.2M | 5.9M | 6.2M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Applied DNA Sciences information on this page should be used as a complementary analysis to other Applied DNA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Applied Stock analysis
When running Applied DNA's price analysis, check to measure Applied DNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied DNA is operating at the current time. Most of Applied DNA's value examination focuses on studying past and present price action to predict the probability of Applied DNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied DNA's price. Additionally, you may evaluate how the addition of Applied DNA to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Applied DNA's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (17.63) | Revenue Per Share 7.666 | Quarterly Revenue Growth (0.79) | Return On Assets (0.64) | Return On Equity (2.52) |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.